APA (7th ed.) Citation

WC, B., S, C., C, S., M, K., S, K., M, W., . . . P, L. (2026). Pharmacokinetic modelling of MRI-based liver function for risk assessment in primary sclerosing cholangitis: A prospective pilot study. European radiology experimental, 10(1), . https://doi.org/10.1186/s41747-026-00764-5

Chicago Style (17th ed.) Citation

WC, Bartholomä, Cai S, Simonsson C, Karlsson M, Kechagias S, Woisetschläger M, Dahlström N, and Lundberg P. "Pharmacokinetic Modelling of MRI-based Liver Function for Risk Assessment in Primary Sclerosing Cholangitis: A Prospective Pilot Study." European Radiology Experimental 10, no. 1 (2026). https://doi.org/10.1186/s41747-026-00764-5.

MLA (9th ed.) Citation

WC, Bartholomä, et al. "Pharmacokinetic Modelling of MRI-based Liver Function for Risk Assessment in Primary Sclerosing Cholangitis: A Prospective Pilot Study." European Radiology Experimental, vol. 10, no. 1, 2026, https://doi.org/10.1186/s41747-026-00764-5.